Attana has launched a redesigned website as an initial step in a new communications and marketing plan

25 September 2020 - 19:48

Attana has launched a redesigned website at with a new graphic profile along with revised content. The website will be continuously updated to ensure accessibility to relevant information as well as improvements in usability and functionality, as needed.

“As we embark on the next chapter in Attana’s history we want our website to set the tone for all of our upcoming communication- and marketing efforts. We are pleased to now provide our customers, partners, and investors with a better understanding of the many benefits our products and services offer,’ comments Teodor Aastrup, CEO Attana.

For more information, please contact:

Teodor Aastrup, CEO Attana AB
tel: + 46 8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.

About Attana

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in-vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit or contact

Provided by: Cision
NGM Nordic SME (Sweden)
Attana AB
Attana conducts research and development of pharmaceuticals. The company specialises in vitro characterization of molecular interactions, which is used for analysis in the development of new pharmaceuticals. The company's patented solutions are mainly used in the study of different binding properties and macrostructures in cells, proteins, viruses, and bacteria. Operations are found mainly within...
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date